FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Probe FDA/Biogen Alzheimers Drug Collaboration: Public Citizen

Public Citizen calls for an immediate HHS Inspector General probe of what it terms FDA collaboration with Biogen on the companys Alzheimers drug aduca...

Human Drugs

Comments on Neurodegenerative Disease FDA Draft Guidance

Three stakeholders comment on an FDA draft guidance on human gene therapy for neurodegenerative diseases.

Medical Devices

Nuvasive Cervical Artificial Disc Approved

FDA approves a NuVasive PMA for its Simplify Cervical Artificial Disc for two-level (XXX DELETE XXX) total disc replacement.

Human Drugs

Court Clarifies CBE Provision, Attorneys Say

Three Sidley Austin attorneys writing for Washington Legal Foundation say a recent 4th Circuit Appeals Court decision increases the burden on plaintif...

Human Drugs

Supernus New ADHD Drug Approved for Kids

FDA approves a Supernus Pharmaceuticals NDA for Qelbree (viloxazine extended-release capsules) for treating attention-deficit hyperactivity disorder i...

Human Drugs

Guide on ANDA Development During Covid

CDER posts a final guidance entitled Development of Abbreviated New Drug Applications During the Covid-19 Pandemic Questions and Answers.

Medical Devices

Surgical Info Sciences 510(k) for Brain Visualization

FDA clears a Surgical Information Sciences 510(k) for an updated algorithm with new visualization capabilities for its SIS System.

Medical Devices

Orthofix 3D Spinal Implant Cleared

FDA clears an Orthofix Medical 510(k) for its 3D-printed Construx Mini Ti Spacer System for use in enhancing anterior cervical discectomy and fusion p...

Medical Devices

Device Group Report on Patient Input

The Medical Device Innovation Consortium releases a new report entitled Maximizing Patient Input in the Design and Development of Medical Device Clini...

Federal Register

NCTR Science Board Meeting 5/11-12

Federal Register notice: FDA announces a 5/11-12 Science Advisory Board to the National Center for Toxicological Research advisory committee meeting.